Hongbo Lu, Ph.D., M.B.A.

Partner, Lilly Asia Ventures

Dr. Hongbo Lu is a Partner at Lilly Asia Ventures (LAV).  Previously, Hongbo was with OrbiMed Advisors, serving as its Managing Director in Asia.  Hongbo has over 15 years of investment and operational experience in healthcare industry in the US and in China, including her tenures at OrbiMed, Piper Jaffray & Co. and Zyomyx.  Hongbo received a Ph.D. in BioEngineering from the University of Washington, an M.B.A. from the Haas School of Business at the University of California, Berkeley, and graduated with honor from Tsinghua University in China.